Wird geladen...
TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is one of the most common urological malignancies. Identifying novel biomarkers and investigating the underlying mechanism of ccRCC development will be crucial to the management and treatment of ccRCC in patients. Thymosin b10 (TMSB10), a member of the thymosi...
Gespeichert in:
| Veröffentlicht in: | Int J Oncol |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
D.A. Spandidos
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7115359/ https://ncbi.nlm.nih.gov/pubmed/32319572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.4991 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|